White Paper: Vendor Selection for Biotechs – What, Why, and How?
Proven strategies from a decade of experience: Choose the best-fit partners, protect your budget, and reach milestones faster.
In this first installment of our insights white paper series, “Vendor Selection for Biotechs – What, Why, and How?” Seuss+ shares proven strategies for smarter vendor selection. Download it now to navigate this crucial step with confidence, protecting your timeline and maximizing your potential.
About the white paper
In this white paper, you will learn how to:
- Maximize Efficiency: Find the right fit the first time – your best-fit CRO partner who accelerates your progress and aligns with your specific needs.
- Mitigate Risks & Save Costs: Discover how a rigorous vendor selection process protects your trial’s budget and timeline.
- Make Decisions with Confidence: Access a decade’s worth of industry expertise to empower informed choices for your biotech’s success.
- Avoid Costly Oversights: Learn from real-world case studies and sidestep common vendor selection pitfalls.
Key Takeaways for Readers:
- The ‘What and Why’ of Vendor Selection: Understand the purpose, benefits, and essential factors to consider throughout the process.
- Common Pitfalls to Avoid: Learn how to sidestep costly pitfalls that can derail trial progress.
- Seuss+ Life Science Expertise: Discover how a specialized consultancy can support you from vendor identification to award.
About Seuss+
Seuss+ is an international life science consultancy with a passion for solving complex challenges for our clients. Through true collaboration, we leverage deep industry knowledge and a proven vendor selection methodology to empower your team’s success. Let us be your partner throughout the exciting journey of transforming innovative science into therapies that improve lives.
Kieran Engels, Author
CEO and Co-Founder, Seuss+
About the Author
Kieran Engels brings a combination of strategic leadership and hands-on industry knowledge to her role as CEO and Co-Founder of Seuss+. Her experience with vendor selection projects over the last 10+ years provides the foundation for her work guiding clients through the vital process of vendor selection. Kieran’s passion for accelerating life science innovation led to the creation of this white paper series, where she offers proven strategies to streamline and optimize your partnerships for successful clinical trials.
Download it now to navigate this crucial step with confidence, protecting your timeline and maximizing your potential.
This is the first white paper in a series of 3.
We are exploring the evolving terrain of vendor selection and analyzing the processes Seuss+ has run with sponsors over the last 10 years.
Sponsors – particularly those at small biotech companies of up to 50 people – will benefit from the surprising, insightful, and practical observations shared throughout the series.
- White paper 1: Vendor selection – what, why and how?
- White paper 2: Navigating the vendor selection process
- White paper 3: Emerging trends and future predictions
Key takeaways
- The first white paper in a series of three on vendor selection for biotechs: what, why, and how.
- Built on proven strategies from a decade of [ogs_entity format="name"] project experience.
- Choose best-fit partners, protect your budget, and reach milestones faster.
Frequently asked questions
Vendor selection for biotechs: what it is, why it matters, and how to run it. It is the first in a series of three.
Small and mid-sized biotech teams who are about to select a CRO or supplier and want to protect budget and timeline while doing it.
A decade of Seuss+ project experience across biotech programs, rather than theory.
Interested to speaking with one of our life science consultants?
At Seuss+, we support, inspire and challenge each other every day. No matter the project, client or task, together, we’ll boldly tackle our industries biggest challenges.
